⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001737979

Mack Gene

Reports to the SEC for 2 companies · BETHESDA, MD

Transactions

6

Companies

2

Filings

6

CIK

0001737979

Forms 4 and 5

Insider transactions

6 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-03-24	GANXGain Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Director, CEO, President	AAward	+200K sh	—	—	200,000
2025-03-20	GANXGain Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Director, CEO, President	AAward	+200K sh	—	—	200,000
2025-01-06	GANXGain Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, CEO, President	AAward	+271K sh	—	—	271,325
2024-08-09	GANXGain Therapeutics, Inc.P Purchase	Director, CEO, President	PPurchase	+14.4K sh	$1.01	+$14.5K	14,400
2024-04-08	GANXGain Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Director, CEO, President	AAward	+200K sh	—	—	200,000
2018-04-20	SLSSELLAS Life Sciences Group, Inc. · Stock Option (Right to Buy)A Award	CFO and Treasurer	AAward	+40K sh	—	—	40,000

Recent filings

6

Accepted (ET)
Mar 264
Mack Gene0001104659-26-035403
SEC(opens sec.gov)
Mar 214
Mack Gene0001493152-25-011175
SEC(opens sec.gov)
Jan 74
Mack Gene0001493152-25-001281
SEC(opens sec.gov)
Aug 124
Mack Gene0001493152-24-031378
SEC(opens sec.gov)
Apr 84
Mack Gene0001493152-24-013983
SEC(opens sec.gov)
Apr 244
Mack Gene0001209191-18-025967
SEC(opens sec.gov)

Companies

2

Address

C/O GAIN THERAPEUTICS, INC. 4800 MONTGOMERY LANE, SUITE 220

BETHESDA, MD, 20814